Afrezza With Basal Combination (ABC): Afrezza® Combined With AID Pump or Insulin Degludec in Adults With Type 1 Diabetes

Clinical trial NCT05243628 · COMPLETED

Trial details

NCT number: NCT05243628
Sponsor: Mannkind Corporation
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Type 1 Diabetes

Start date: 2022-03-31
Primary completion: 2022-10-17
Enrollment: 33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.